Gene · 406931
Papers2,257
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,257
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human Left Ventricle circRNA-miRNA-mRNA Network Analyses Reveal a Novel Proangiogenic Role for circNPHP1 Under Ischemic Conditions. | JACC Basic Transl Sci | 2026 | 41564714 | PubTator, text mining | PubMed |
| Downregulation of miR-139 in lung cancer promotes metastasis via ERBB2/Rac1/NF-κB signaling axis. | Pak J Pharm Sci | 2026 | 41482782 | PubTator, text mining | PubMed |
| Preconditioning strategies for stem cells and exosomes: Transformative potential in diabetic wound treatment: A review. | Int J Biol Macromol | 2026 | 41352497 | PubTator, text mining | PubMed |
| Development of serum glycosylated exosomal microRNAs as biomarkers for early diagnosis of lung adenocarcinoma. | Front Med (Lausanne) | 2025 | 41451087 | PubTator, text mining | PubMed |
| MicroRNA alterations in sperm of infertile men: Insights into oligozoospermia, asthenozoospermia, and teratozoospermia. | Biotechnol Notes | 2025 | 41235370 | PubTator, text mining | PubMed |
| Epigenetic modification of cuproptosis by non-coding RNAs in cancer drug resistance. | Mol Cancer | 2025 | 40999456 | PubTator, text mining | PubMed |
| Extracellular vesicles as biomarkers for endometrial cancer - A systematic review. | Transl Oncol | 2025 | 40987065 | PubTator, text mining | PubMed |
| FTO-regulated m6A modification of pri-miR-139 represses papillary thyroid carcinoma metastasis. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2025 | 40916819 | PubTator, text mining | PubMed |
| Partners in Silencing: Decoding the Mammalian Argonaute Interactome. | Noncoding RNA | 2025 | 40863728 | PubTator, text mining | PubMed |
| Mechanistic Insights and Clinical Implications of ELK1 in Solid Tumors: A Narrative Review. | Cells | 2025 | 40862737 | PubTator, text mining | PubMed |
| Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers. | Mol Cancer | 2025 | 40847302 | PubTator, text mining | PubMed |
| Comparative Analysis of miRNA Expression 106a-5p and 375-3p and Proteins ERK1/2, p38, β-Catenin and E-Cadherin in Prostate Cancer and Benign Prostatic Hyperplasia. | J Cell Mol Med | 2025 | 40839490 | PubTator, text mining | PubMed |
| Opposing mechanisms by which miRNAs mediate distinct Nrf1 and Nrf2 regulation of epithelial-mesenchymal transition in hepatocellular carcinoma. | RNA Biol | 2025 | 40836845 | PubTator, text mining | PubMed |
| Construction and Validation of a Nomogram for Postoperative Survival Prognosis in Gastric Cancer Patients Based on miR-139, Nuclear Factor Erythroid2-Related Factor 2, and miR-7. | Clin Oncol (R Coll Radiol) | 2025 | 40803238 | PubTator, text mining | PubMed |
| N7-methylguanosine (m7G) modification in breast cancer: clinical significances and molecular mechanisms. | Cancer Cell Int | 2025 | 40797255 | PubTator, text mining | PubMed |
| Extracellular vesicle miRNA signatures in pediatric onset-multiple sclerosis and obesity-driven immune and metabolic dysregulation. | medRxiv | 2025 | 40791677 | PubTator, text mining | PubMed |
| MicroRNAs in exhaled breath Condensate: Novel non-invasive biomarkers for tuberculosis diagnosis. | Tuberculosis (Edinb) | 2025 | 40684536 | PubTator, text mining | PubMed |
| A novel miRNA-based model for predicting the 3-year recurrence risk of hepatocellular carcinoma following liver transplantation. | J Gastrointest Oncol | 2025 | 40672061 | PubTator, text mining | PubMed |
| Modulation of hypoxia-sensitive non-coding RNAs following continuous positive airway pressure therapy in obstructive sleep apnea in peripheral blood. | Eur J Intern Med | 2025 | 40603222 | PubTator, text mining | PubMed |
| Tumor Suppressor miRNA-based Signatures in Triple Negative Breast Cancer: A Study Based on Big Data Analysis of Gene Expression Omnibus (GEO) Datasets and Its Validation. | Asian Pac J Cancer Prev | 2025 | 40542771 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406931/papers?page=2